Advertisement

Neuropsychology Review

, Volume 28, Issue 3, pp 317–340 | Cite as

Social Function and Autism Spectrum Disorder in Children and Adults with Neurofibromatosis Type 1: a Systematic Review and Meta-Analysis

  • Anita K. Chisholm
  • Vicki A. Anderson
  • Natalie A. Pride
  • Stephanie Malarbi
  • Kathryn N. North
  • Jonathan M. Payne
Review

Abstract

In light of the proliferation of recent research into social function in neurofibromatosis type 1 (NF1), a systematic review and meta-analysis is required to synthesise data and place findings within the context of a theoretical framework. This paper reviews findings from research into social function and autism spectrum disorder (ASD) in children and adults with NF1 and integrates these findings with the Socio-Cognitive Integration Abilities Model (SOCIAL). It also critically appraises links between social outcomes, internal and external factors moderating social functioning, cognitive domains implicated in social functioning, and underlying neural pathology in NF1. A systematic literature search conducted in MedLine (Ovid), PsycINFO (Ovid), Embase (Ovid), and PubMed electronic databases yielded 35 papers that met inclusion criteria for the systematic review. Out of these papers, 22 papers provided sufficient data for meta-analysis. Findings from this review and meta-analysis provide evidence that children and adults with NF1 exhibit significantly higher prevalence and severity of social dysfunction and ASD symptomatology. To date, very few studies have examined social cognition in NF1 but results indicate the presence of both perceptual and higher-level impairments in this population. The results of this review also provide support for age, gender, and comorbid ADHD as moderating factors for social outcomes in NF1. Suggestions for future research are offered to further our understanding of the social phenotype in NF1 and to facilitate the development of targeted interventions.

Keywords

Neurofibromatosis type 1 Social function Social perception Social cognition Autism spectrum disorder 

Notes

Acknowledgments

The authors acknowledge the assistance of Poh Chua (RCH) for guidance on conducting systematic database searches.

Supplementary material

11065_2018_9380_MOESM1_ESM.docx (54 kb)
ESM 1 (DOCX 53.9 kb)

References

  1. Abdi, B. (2010). Gender differences in social skills, problem behaviours and academic competence of Iranian kindergarten children based on their parent and teacher ratings. Procedia-Social and Behavioral Sciences, 5, 1175–1179.CrossRefGoogle Scholar
  2. Achenbach, T. M. (1991). Manual for the Child Behavior Checklist/4–18 and 1991 profile: Department of Psychiatry. VT: University of Vermont Burlington.Google Scholar
  3. Achenbach, T. M., McConaughy, S. H., & Howell, C. T. (1987). Child/adolescent behavioral and emotional problems: Implications of cross-informant correlations for situational specificity. Psychological Bulletin, 101(2), 213–232.PubMedCrossRefGoogle Scholar
  4. Addington, J., & Addington, D. (1999). Neurocognitive and social functioning in schizophrenia. Schizophrenia Bulletin, 25(1), 173–182.PubMedCrossRefGoogle Scholar
  5. Adolphs, R. (2001). The neurobiology of social cognition. Current Opinion in Neurobiology, 11(2), 231–239.PubMedCrossRefGoogle Scholar
  6. Adviento, B., Corbin, I. L., Widjaja, F., Desachy, G., Enrique, N., Rosser, T., Risi, S., Marco, E. J., Hendren, R. L., Bearden, C. E., Rauen, K. A., & Weiss, L. A. (2014). Autism traits in the RASopathies. Journal of Medical Genetics, 51(1), 10–20.PubMedCrossRefGoogle Scholar
  7. Allen, T., Willard, V. W., Anderson, L. M., Hardy, K. K., & Bonner, M. J. (2016). Social functioning and facial expression recognition in children with neurofibromatosis type 1. Journal of Intellectual Disability Research, 60(3), 282–293.PubMedCrossRefGoogle Scholar
  8. Anderson, V., & Beauchamp, M. H. (2012). Developmental social neuroscience and childhood brain insult: Theory and practice: Guilford press.Google Scholar
  9. Angkustsiri, K., Goodlin-Jones, B., Deprey, L., Brahmbhatt, K., Harris, S., & Simon, T. J. (2014). Social impairments in chromosome 22q11. 2 deletion syndrome (22q11. 2DS): Autism spectrum disorder or a different endophenotype? Journal of Autism and Developmental Disorders, 44(4), 739–746.PubMedPubMedCentralCrossRefGoogle Scholar
  10. Anzures-Cabrera, J., & Higgins, J. (2010). Graphical displays for meta-analysis: An overview with suggestions for practice. Research Synthesis Methods, 1(1), 66–80.PubMedCrossRefGoogle Scholar
  11. Barton, B., & North, K. (2004). Social skills of children with neurofibromatosis type 1. Developmental Medicine & Child Neurology, 46(8), 553–563.CrossRefGoogle Scholar
  12. Barton, B., & North, K. (2007). The self-concept of children and adolescents with neurofibromatosis type 1. Child: Care, Health & Development, 33(4), 401–408.Google Scholar
  13. Baskin Jr., H. J. (2008). The pathogenesis and imaging of the tuberous sclerosis complex. Pediatric Radiology, 38(9), 936–952.PubMedCrossRefGoogle Scholar
  14. Beauchamp, M. H., & Anderson, V. (2010). SOCIAL: An integrative framework for the development of social skills. Psychological Bulletin, 136(1), 39–64.PubMedCrossRefGoogle Scholar
  15. Bent, C. A., Dissanayake, C., & Barbaro, J. (2015). Mapping the diagnosis of autism spectrum disorders in children aged under 7 years in Australia, 2010-2012. The Medical Journal of Australia, 202(6), 317–320.PubMedCrossRefGoogle Scholar
  16. Bicudo, N. P., de Menezes Neto, B. F., da Silva de Avo, L. R., Germano, C. M., & Melo, D. G. (2016). Quality of life in adults with Neurofibromatosis 1 in Brazil. Journal of Genetic Counseling, 25(5), 1063–1074.PubMedCrossRefGoogle Scholar
  17. Bolton, P., Clifford, M., Tye, C., Maclean, C., Humphrey, A., Le Marechal, K., et al. (2015). Intellectual abilities in tuberous sclerosis complex: Risk factors and correlates from the tuberous sclerosis 2000 study. Psychological Medicine, 45(11), 2321–2331.PubMedCrossRefGoogle Scholar
  18. Borenstein, M., Hedges, L. V., & Higgins, J. P. (2009). Introduction to meta-analysis. Chichester: Wiley..CrossRefGoogle Scholar
  19. Borenstein, M., Hedges, L., Higgins, J., & Rothstein, H. (2014). Comprehensive meta-analysis version 3.0 [computer software]. Englewood: Biostat.Google Scholar
  20. Bruni, T. P. (2014). Test review: Social responsiveness scale–second edition (SRS-2). Los Angeles: SAGE Publications Sage CA.Google Scholar
  21. Cantwell, D. P. (1996). Attention deficit disorder: A review of the past 10 years. Journal of the American Academy of Child & Adolescent Psychiatry, 35(8), 978–987.CrossRefGoogle Scholar
  22. Charman, T., Pickles, A., Simonoff, E., Chandler, S., Loucas, T., & Baird, G. (2011). IQ in children with autism spectrum disorders: Data from the special needs and autism project (SNAP). Psychological Medicine, 41(3), 619–627.PubMedCrossRefGoogle Scholar
  23. Cholemkery, H., Kitzerow, J., Rohrmann, S., & Freitag, C. M. (2014). Validity of the social responsiveness scale to differentiate between autism spectrum disorders and disruptive behaviour disorders. European Child & Adolescent Psychiatry, 23(2), 81–93.CrossRefGoogle Scholar
  24. Christensen, D. L. (2016). Prevalence and characteristics of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2012. MMWR. Surveillance Summaries, 65(3), 1–23.CrossRefGoogle Scholar
  25. Cipolletta, S., Spina, G., & Spoto, A. (2017). Psychosocial functioning, self-image, and quality of life in children and adolescents with neurofibromatosis type 1. Child: Care, Health & Development, 44(2), 260–268.  https://doi.org/10.1111/cch.12496.CrossRefGoogle Scholar
  26. Clark, T., Feehan, C., Tinline, C., & Vostanis, P. (1999). Autistic symptoms in children with attention deficit-hyperactivity disorder. European Child & Adolescent Psychiatry, 8(1), 50–55.CrossRefGoogle Scholar
  27. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (p. 2). Hilsdale: Lawrence Earlbaum Associates.Google Scholar
  28. Cohen, J. (1992). Statistical power analysis. Current Directions in Psychological Science, 1(3), 98–101.CrossRefGoogle Scholar
  29. Cohen, R., Steinberg, T., Kornreich, L., Aharoni, S., Halevy, A., & Shuper, A. (2015). Brain imaging findings and social/emotional problems in Israeli children with neurofibromatosis type 1. European Journal of Pediatrics, 174(2), 199–203.PubMedCrossRefGoogle Scholar
  30. Constantino, J. N., & Gruber, C. P. (2012). Social responsiveness scale (Second ed.). Los Angeles: Western Psychological Services.Google Scholar
  31. Constantino, J. N., & Todd, R. D. (2005). Intergenerational transmission of subthreshold autistic traits in the general population. Biological Psychiatry, 57(6), 655–660.PubMedCrossRefGoogle Scholar
  32. Constantino, J. N., Davis, S. A., Todd, R. D., Schindler, M. K., Gross, M. M., Brophy, S. L., Metzger, L. M., Shoushtari, C. S., Splinter, R., & Reich, W. (2003). Validation of a brief quantitative measure of autistic traits: Comparison of the social responsiveness scale with the autism diagnostic interview-revised. Journal of Autism and Developmental Disorders, 33(4), 427–433.PubMedCrossRefGoogle Scholar
  33. Constantino, J. N., Zhang, Y., Holzhauer, K., Sant, S., Long, K., Vallorani, A., Malik, L., & Gutmann, D. H. (2015). Distribution and within-family specificity of quantitative autistic traits in patients with Neurofibromatosis type I. Journal of Pediatrics, 167(3), 621–626 e621.PubMedCrossRefGoogle Scholar
  34. Craig, F., Margari, F., Legrottaglie, A. R., Palumbi, R., de Giambattista, C., & Margari, L. (2016). A review of executive function deficits in autism spectrum disorder and attention-deficit/hyperactivity disorder. Neuropsychiatric Disease and Treatment, 12, 1191.PubMedPubMedCentralGoogle Scholar
  35. Croen, L. A., Grether, J. K., Hoogstrate, J., & Selvin, S. (2002). The changing prevalence of autism in California. Journal of Autism and Developmental Disorders, 32(3), 207–215.PubMedCrossRefGoogle Scholar
  36. Dalton, K. M., Nacewicz, B. M., Johnstone, T., Schaefer, H. S., Gernsbacher, M. A., Goldsmith, H. H., Alexander, A. L., & Davidson, R. J. (2005). Gaze fixation and the neural circuitry of face processing in autism. Nature Neuroscience, 8(4), 519–526.PubMedPubMedCentralCrossRefGoogle Scholar
  37. Dilts, C. V., Carey, J. C., Kircher, J. C., Hoffman, R. O., Creel, D., Ward, K., Clark, E., & Leonard, C. O. (1996). Children and adolescents with neurofibromatosis 1: A behavioral phenotype. Journal of Developmental & Behavioral Pediatrics, 17(4), 229–239.CrossRefGoogle Scholar
  38. Durkin, M. S., Maenner, M. J., Meaney, F. J., Levy, S. E., DiGuiseppi, C., Nicholas, J. S., Kirby, R. S., Pinto-Martin, J. A., & Schieve, L. A. (2010). Socioeconomic inequality in the prevalence of autism spectrum disorder: Evidence from a US cross-sectional study. PLoS One, 5(7), e11551.PubMedPubMedCentralCrossRefGoogle Scholar
  39. Duval, S., & Tweedie, R. (2000). Trim and fill: A simple funnel-plot–based method of testing and adjusting for publication bias in meta-analysis. Biometrics, 56(2), 455–463.PubMedCrossRefGoogle Scholar
  40. Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. British Medical Journal, 315(7109), 629–634.PubMedCrossRefGoogle Scholar
  41. Evans, D. G., Howard, E., Giblin, C., Clancy, T., Spencer, H., Huson, S. M., & Lalloo, F. (2010). Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service. American Journal of Medical Genetics Part A, 152A(2), 327–332.PubMedCrossRefGoogle Scholar
  42. Fombonne, E. (2009). Epidemiology of pervasive developmental disorders. Pediatric Research, 65(6), 591–598.PubMedCrossRefGoogle Scholar
  43. Fung, L. K., & Reiss, A. L. (2015). Moving towards integrative, multi-dimensional research in modern psychiatry: Lessons learned from fragile x syndrome. Biological Psychiatry, 80(2), 100–111.PubMedPubMedCentralCrossRefGoogle Scholar
  44. Garg, S., Green, J., Leadbitter, K., Emsley, R., Lehtonen, A., Evans, D. G., & Huson, S. M. (2013a). Neurofibromatosis type 1 and autism spectrum disorder. Pediatrics, 132(6), e1642–e1648.PubMedCrossRefGoogle Scholar
  45. Garg, S., Lehtonen, A., Huson, S. M., Emsley, R., Trump, D., Evans, D. G., et al. (2013b). Autism and other psychiatric comorbidity in neurofibromatosis type 1: Evidence from a population-based study. Developmental Medicine & Child Neurology, 55(2), 139–145.CrossRefGoogle Scholar
  46. Garg, S., Plasschaert, E., Descheemaeker, M.-J., Huson, S., Borghgraef, M., Vogels, A., Evans, D. G., Legius, E., & Green, J. (2015). Autism spectrum disorder profile in neurofibromatosis type I. Journal of Autism and Developmental Disorders, 45(6), 1649–1657.PubMedCrossRefGoogle Scholar
  47. Garg, S., Heuvelman, H., Huson, S., Tobin, H., & Green, J. (2016). Sex bias in autism spectrum disorder in neurofibromatosis type 1. Journal of Neurodevelopmental Disorders, 8(1), 1.CrossRefGoogle Scholar
  48. Golan, O., Ashwin, E., Granader, Y., McClintock, S., Day, K., Leggett, V., & Baron-Cohen, S. (2010). Enhancing emotion recognition in children with autism spectrum conditions: An intervention using animated vehicles with real emotional faces. Journal of Autism and Developmental Disorders, 40(3), 269–279.PubMedCrossRefGoogle Scholar
  49. Goodman, R. (1997). The strengths and difficulties questionnaire: A research note. Journal of Child Psychology and Psychiatry, 38(5), 581–586.PubMedCrossRefPubMedCentralGoogle Scholar
  50. Graf, A., Landolt, M. A., Mori, A. C., & Boltshauser, E. (2006). Quality of life and psychological adjustment in children and adolescents with neurofibromatosis type 1. Journal of Pediatrics, 149(3), 348–353.PubMedCrossRefGoogle Scholar
  51. Gresham, F., & Elliot, S. (1990). Manual for the social skills rating system. Circle Pines: American Guidance Service.Google Scholar
  52. Group, W. (1998). The WHOQL assessment instrument: Development and general psychometric properties. Social Science and Medicine, 46, 1585–1596.Google Scholar
  53. Hadwin, J., Baron-Cohen, S., Howlin, P., & Hill, K. (1996). Can we teach children with autism to understand emotions, belief, or pretence? Development and Psychopathology, 8(02), 345–365.CrossRefGoogle Scholar
  54. Hagerman, R. J., Berry-Kravis, E., Kaufmann, W. E., Ono, M. Y., Tartaglia, N., Lachiewicz, A., Kronk, R., Delahunty, C., Hessl, D., Visootsak, J., Picker, J., Gane, L., & Tranfaglia, M. (2009). Advances in the treatment of fragile X syndrome. Pediatrics, 123(1), 378–390.PubMedPubMedCentralCrossRefGoogle Scholar
  55. Happe, F., Ronald, A., & Plomin, R. (2006). Time to give up on a single explanation for autism. Nature Neuroscience, 9(10), 1218–1220.PubMedCrossRefGoogle Scholar
  56. Hedges, L. V., & Pigott, T. D. (2004). The power of statistical tests for moderators in meta-analysis. Psychological Methods, 9(4), 426–445.PubMedCrossRefGoogle Scholar
  57. Hirabaru, K., & Matsuo, M. (2017). Neurological comorbidity in children with neurofibromatosis type 1. Pediatrics International, 60(1), 70–75.  https://doi.org/10.1111/ped.13388.PubMedCrossRefGoogle Scholar
  58. Hofman, K. J., Harris, E. L., Bryan, R. N., & Denckla, M. B. (1994). Neurofibromatosis type 1: The cognitive phenotype. Journal of Pediatrics, 124(4), S1–S8.PubMedCrossRefGoogle Scholar
  59. Huedo-Medina, T. B., Sánchez-Meca, J., Marín-Martínez, F., & Botella, J. (2006). Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychological Methods, 11(2), 193–206.PubMedCrossRefGoogle Scholar
  60. Huijbregts, S. C., & de Sonneville, L. M. (2011). Does cognitive impairment explain behavioral and social problems of children with neurofibromatosis type 1? Behavior Genetics, 41(3), 430–436.PubMedCrossRefGoogle Scholar
  61. Huijbregts, S., Jahja, R., De Sonneville, L., De Breij, S., & Swaab-Barneveld, H. (2010). Social information processing in children and adolescents with neurofibromatosis type 1. Developmental Medicine & Child Neurology, 52(7), 620–625.CrossRefGoogle Scholar
  62. Huijbregts, S. C., Loitfelder, M., Rombouts, S. A., Swaab, H., Verbist, B. M., Arkink, E. B., van Buchem, M. A., & Veer, I. M. (2015). Cerebral volumetric abnormalities in Neurofibromatosis type 1: Associations with parent ratings of social and attention problems, executive dysfunction, and autistic mannerisms. Journal of Neurodevelopmental Disorders, 7(1), 32.PubMedPubMedCentralCrossRefGoogle Scholar
  63. Hus, V., Bishop, S., Gotham, K., Huerta, M., & Lord, C. (2013). Factors influencing scores on the social responsiveness scale. Journal of Child Psychology and Psychiatry, 54(2), 216–224.PubMedCrossRefGoogle Scholar
  64. Hyman, S. L., Shores, A., & North, K. N. (2005). The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology, 65(7), 1037–1044.PubMedCrossRefGoogle Scholar
  65. Hyman, S. L., Shores, A. E., & North, K. N. (2006). Learning disabilities in children with neurofibromatosis type 1: Subtypes, cognitive profile, and attention-deficit-hyperactivity disorder. Developmental Medicine & Child Neurology, 48(12), 973–977.CrossRefGoogle Scholar
  66. Jeste, S. S., & Geschwind, D. H. (2014). Disentangling the heterogeneity of autism spectrum disorder through genetic findings. Nature Reviews Neurology, 10(2), 74–81.PubMedPubMedCentralCrossRefGoogle Scholar
  67. Johnson, N. S., Saal, H. M., Lovell, A. M., & Schorry, E. K. (1999). Social and emotional problems in children with neurofibromatosis type 1: Evidence and proposed interventions. Journal of Pediatrics, 134(6), 767–772.PubMedCrossRefGoogle Scholar
  68. Johnson, W., Bouchard, T. J., Krueger, R. F., McGue, M., & Gottesman, I. I. (2004). Just one g: Consistent results from three test batteries. Intelligence, 32(1), 95–107.CrossRefGoogle Scholar
  69. Johnson, H., Wiggs, L., Stores, G., & Huson, S. M. (2005). Psychological disturbance and sleep disorders in children with neurofibromatosis type 1. Developmental Medicine & Child Neurology, 47(4), 237–242.CrossRefGoogle Scholar
  70. Kenworthy, L., Case, L., Harms, M. B., Martin, A., & Wallace, G. L. (2010). Adaptive behavior ratings correlate with symptomatology and IQ among individuals with high-functioning autism spectrum disorders. Journal of Autism and Developmental Disorders, 40(4), 416–423.PubMedPubMedCentralCrossRefGoogle Scholar
  71. Klein-Tasman, B. P., Janke, K. M., Luo, W., Casnar, C. L., Hunter, S. J., Tonsgard, J., Trapane, P., van der Fluit, F., & Kais, L. A. (2014). Cognitive and psychosocial phenotype of young children with neurofibromatosis-1. Journal of the International Neuropsychological Society, 20(1), 88–98.PubMedCrossRefGoogle Scholar
  72. Korf, B. R. (2002). Clinical features and pathobiology of neurofibromatosis 1. Journal of Child Neurology, 17(8), 573–577.PubMedCrossRefGoogle Scholar
  73. Krab, L. C., de Goede-Bolder, A., Aarsen, F. K., Pluijm, S. M., Bouman, M. J., van der Geest, J. N., et al. (2008). Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: A randomized controlled trial. Journal of the American Medical Association, 300(3), 287–294.PubMedCrossRefGoogle Scholar
  74. Lai, M. C., Lombardo, M. V., & Baron-Cohen, S. (2014). Autism. Lancet, 383(9920), 896–910.PubMedCrossRefGoogle Scholar
  75. Lainhart, J. E., Bigler, E. D., Bocian, M., Coon, H., Dinh, E., Dawson, G., Deutsch, C. K., Dunn, M., Estes, A., Tager-Flusberg, H., Folstein, S., Hepburn, S., Hyman, S., McMahon, W., Minshew, N., Munson, J., Osann, K., Ozonoff, S., Rodier, P., Rogers, S., Sigman, M., Spence, M. A., Stodgell, C. J., & Volkmar, F. (2006). Head circumference and height in autism: A study by the collaborative program of excellence in autism. American Journal of Medical Genetics Part A, 140(21), 2257–2274.PubMedPubMedCentralCrossRefGoogle Scholar
  76. Le Couteur, A., Lord, C., & Rutter, M. (2003). The autism diagnostic interview-revised (ADI-R). Los Angeles: Western Psychological Services.Google Scholar
  77. Lehtonen, A., Howie, E., Trump, D., & Huson, S. M. (2013). Behaviour in children with neurofibromatosis type 1: Cognition, executive function, attention, emotion, and social competence. Developmental Medicine & Child Neurology, 55(2), 111–125.CrossRefGoogle Scholar
  78. Lewis, A. K., Porter, M. A., Williams, T. A., North, K. N., & Payne, J. M. (2016). Social competence in children with neurofibromatosis type 1: Relationships with psychopathology and cognitive ability. Journal of Childhood & Developmental Disorders, 2(2), 1–12.CrossRefGoogle Scholar
  79. Lewis, A. K., Porter, M. A., Williams, T. A., Bzishvili, S., North, K. N., & Payne, J. M. (2017). Facial emotion recognition, face scan paths, and face perception in children with neurofibromatosis type 1. Neuropsychology, 31(4), 361–370.PubMedCrossRefGoogle Scholar
  80. Li, W., Cui, Y., Kushner, S. A., Brown, R. A., Jentsch, J. D., Frankland, P. W., et al. (2005). The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Current Biology, 15(21), 1961–1967.PubMedCrossRefGoogle Scholar
  81. Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P., et al. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration. British Medical Journal, 339(jul21 1), b2700.PubMedCrossRefGoogle Scholar
  82. Loitfelder, M., Huijbregts, S. C., Veer, I. M., Swaab, H. S., Van Buchem, M. A., Schmidt, R., et al. (2015). Functional connectivity changes and executive and social problems in Neurofibromatosis type I. Brain Connectivity, 5(5), 312–320.PubMedPubMedCentralCrossRefGoogle Scholar
  83. Loomes, R., Hull, L., & Mandy, W. P. L. (2017). What is the male-to-female ratio in autism Spectrum disorder? A systematic review and meta-analysis. Journal of the American Academy of Child & Adolescent Psychiatry, 56(6), 466–474.CrossRefGoogle Scholar
  84. Lord, C., Risi, S., Lambrecht, L., Cook Jr., E. H., Leventhal, B. L., DiLavore, P. C., et al. (2000). The autism diagnostic observation schedule-generic: A standard measure of social and communication deficits associated with the spectrum of autism. Journal of Autism and Developmental Disorders, 30(3), 205–223.PubMedCrossRefGoogle Scholar
  85. Love, E. B., Nowicki Jr., S., & Duke, M. P. (1994). The Emory Dyssemia index: A brief screening instrument for the identification of nonverbal language deficits in elementary school children. The Journal of Psychology, 128(6), 703–705.PubMedCrossRefGoogle Scholar
  86. Lowe, M. R., & Cautela, J. R. (1978). A self-report measure of social skill. Behavior Therapy, 9(4), 535–544.CrossRefGoogle Scholar
  87. Luteijn, E., Minderaa, R., & Jackson, A. (2002). Vragenlijst voor Inventarisatie van Sociaal gedrag bij Kinderen, Handleiding [Children’s Social Behaviour Questionnaire, Manual]. Lisse: Swets & Zeitlinger.Google Scholar
  88. Maenner, M. J., Schieve, L. A., Rice, C. E., Cunniff, C., Giarelli, E., Kirby, R. S., Lee, L. C., Nicholas, J. S., Wingate, M. S., & Durkin, M. S. (2013). Frequency and pattern of documented diagnostic features and the age of autism identification. Journal of the American Academy of Child & Adolescent Psychiatry, 52(4), 401–413 e408.CrossRefGoogle Scholar
  89. Mansbach-Kleinfeld, I., Apter, A., Farbstein, I., Levine, S. Z., & Ponizovsky, A. M. (2010). A population-based psychometric validation study of the strengths and difficulties questionnaire - hebrew version. Frontiers in Psychiatry, 1, 151.PubMedPubMedCentralCrossRefGoogle Scholar
  90. Martin, S., Wolters, P., Baldwin, A., Gillespie, A., Dombi, E., Walker, K., et al. (2012). Social-emotional functioning of children and adolescents with neurofibromatosis type 1 and plexiform neurofibromas: Relationships with cognitive, disease, and environmental variables. Journal of Pediatric Psychology, 37(7), 713–724.PubMedPubMedCentralCrossRefGoogle Scholar
  91. Masi, A., DeMayo, M. M., Glozier, N., & Guastella, A. J. (2017). An overview of autism spectrum disorder, heterogeneity and treatment options. Neuroscience Bulletin, 1–11.Google Scholar
  92. Masten, A. S., Morison, P., & Pellegrini, D. S. (1985). A revised class play method of peer assessment. Developmental Psychology, 21(3), 523–533.CrossRefGoogle Scholar
  93. Mautner, V. F., Kluwe, L., Thakker, S. D., & Leark, R. A. (2002). Treatment of ADHD in neurofibromatosis type 1. Developmental Medicine & Child Neurology, 44(3), 164–170.CrossRefGoogle Scholar
  94. Mayes, S. D., Calhoun, S. L., Mayes, R. D., & Molitoris, S. (2012). Autism and ADHD: Overlapping and discriminating symptoms. Research in Autism Spectrum Disorders, 6(1), 277–285.CrossRefGoogle Scholar
  95. McLoyd, V. C. (1998). Socioeconomic disadvantage and child development. American Psychologist, 53(2), 185–204.PubMedCrossRefGoogle Scholar
  96. Molosh, A. I., Johnson, P. L., Spence, J. P., Arendt, D., Federici, L. M., Bernabe, C., et al. (2014). Social learning and amygdala disruptions in Nf1 mice are rescued by blocking p21-activated kinase. Nature Neuroscience, 17(11), 1583–1590.PubMedPubMedCentralCrossRefGoogle Scholar
  97. Moos, R. H., & Moos, B. S. (1994). Family environment scale manual. Consulting Psychologists Press.Google Scholar
  98. Morris, S. M., Acosta, M. T., Garg, S., Green, J., Huson, S., Legius, E., et al. (2016). Disease burden and symptom structure of autism in Neurofibromatosis type 1: A study of the international NF1-ASD consortium team (INFACT). JAMA Psychiatry, 73(12), 1276–1284.PubMedPubMedCentralCrossRefGoogle Scholar
  99. Neurofibromatosis. (1988). Neurofibromatosis. Conference statement. National Institutes of Health consensus development conference. Archives of Neurology, 45(5), 575–578.CrossRefGoogle Scholar
  100. Nisbett, R. E., Aronson, J., Blair, C., Dickens, W., Flynn, J., Halpern, D. F., et al. (2012). Intelligence: New findings and theoretical developments. American Psychologist, 67(2), 130–159.PubMedCrossRefGoogle Scholar
  101. Noll, R. B., Reiter-Purtill, J., Moore, B. D., Schorry, E. K., Lovell, A. M., Vannatta, K., et al. (2007). Social, emotional, and behavioral functioning of children with NF1. American Journal of Medical Genetics Part A, 143A(19), 2261–2273.PubMedCrossRefGoogle Scholar
  102. Packer, A. (2012). RAS pathway, a potentially unifying theory of autism. Simons Foundation Autism Research Initiative, 13.Google Scholar
  103. Payne, J. M. (2013). Autism spectrum disorder symptomatology in children with neurofibromatosis type 1. Developmental Medicine & Child Neurology, 55(2), 100–101.CrossRefGoogle Scholar
  104. Payne, J. M., Moharir, M. D., Webster, R., & North, K. N. (2010). Brain structure and function in neurofibromatosis type 1: Current concepts and future directions. Journal of Neurology, Neurosurgery and Psychiatry, 81(3), 304–309.PubMedCrossRefGoogle Scholar
  105. Payne, J. M., Barton, B., Ullrich, N. J., Cantor, A., Hearps, S. J., Cutter, G., et al. (2016a). Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1. Neurology, 87(24), 2575–2584.PubMedPubMedCentralCrossRefGoogle Scholar
  106. Payne, J. M., Porter, M., Pride, N. A., & North, K. N. (2016b). Theory of mind in children with Neurofibromatosis type 1. Neuropsychology, 30(4), 439–448.PubMedCrossRefGoogle Scholar
  107. Plasschaert, E., Descheemaeker, M.-J., Van Eylen, L., Noens, I., Steyaert, J., & Legius, E. (2015). Prevalence of autism spectrum disorder symptoms in children with neurofibromatosis type 1. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 168(1), 72–80.CrossRefGoogle Scholar
  108. Plasschaert, E., Van Eylen, L., Descheemaeker, M. J., Noens, I., Legius, E., & Steyaert, J. (2016). Executive functioning deficits in children with neurofibromatosis type 1: The influence of intellectual and social functioning. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 171(3), 348–362.CrossRefGoogle Scholar
  109. Pride, N. A., Crawford, H., Payne, J. M., & North, K. N. (2013). Social functioning in adults with neurofibromatosis type 1. Research in Developmental Disabilities, 34(10), 3393–3399.PubMedCrossRefGoogle Scholar
  110. Pride, N. A., Korgaonkar, M. S., Barton, B., Payne, J. M., Vucic, S., & North, K. N. (2014). The genetic and neuroanatomical basis of social dysfunction: Lessons from neurofibromatosis type 1. Human Brain Mapping, 35(5), 2372–2382.PubMedCrossRefGoogle Scholar
  111. Pride, N. A., Korgaonkar, M. S., North, K. N., Barton, B., & Payne, J. M. (2017a). The neural basis of deficient response inhibition in children with neurofibromatosis type 1: Evidence from a functional MRI study. Cortex, 93, 1–11.PubMedCrossRefGoogle Scholar
  112. Pride, N. A., Korgaonkar, M. S., North, K. N., & Payne, J. M. (2017b). Impaired engagement of the ventral attention system in neurofibromatosis type 1. Brain Imaging and Behavior, 1–10.Google Scholar
  113. Pua, E. P. K., Bowden, S. C., & Seal, M. L. (2017). Autism spectrum disorders: Neuroimaging findings from systematic reviews. Research in Autism Spectrum Disorders, 34, 28–33.CrossRefGoogle Scholar
  114. Renk, K., & Phares, V. (2004). Cross-informant ratings of social competence in children and adolescents. Clinical Psychology Review, 24(2), 239–254.PubMedCrossRefGoogle Scholar
  115. Reynolds, C. R., & Kamphaus, R. W. (1998). BASC: Behavior assessment system for children: Manual: American Guidance Service.Google Scholar
  116. Robins, D. L., & Dumont-Mathieu, T. M. (2006). Early screening for autism spectrum disorders: Update on the modified checklist for autism in toddlers and other measures. Journal of Developmental & Behavioral Pediatrics, 27(2 Suppl), S111–S119.CrossRefGoogle Scholar
  117. Rutter, M., Bailey, A., & Lord, C. (2003). The Social Communication Questionnaire: Manual: Western psychological services.Google Scholar
  118. Schatz, J., & Hamdan-Allen, G. (1995). Effects of age and IQ on adaptive behavior domains for children with autism. Journal of Autism and Developmental Disorders, 25(1), 51–60.PubMedCrossRefGoogle Scholar
  119. Schwetye, K. E., & Gutmann, D. H. (2014). Cognitive and behavioral problems in children with neurofibromatosis type 1: Challenges and future directions. Expert Review of Neurotherapeutics, 14(10), 1139–1152.PubMedCrossRefGoogle Scholar
  120. Speer, L. L., Cook, A. E., McMahon, W. M., & Clark, E. (2007). Face processing in children with autism: Effects of stimulus contents and type. Autism, 11(3), 265–277.PubMedCrossRefGoogle Scholar
  121. Spence, S. H. (1995). Social skills training: Enhancing social competence with children and adolescents: Nfer-Nelson.Google Scholar
  122. Thomas, P., Zahorodny, W., Peng, B., Kim, S., Jani, N., Halperin, W., et al. (2012). The association of autism diagnosis with socioeconomic status. Autism, 16(2), 201–213.PubMedCrossRefGoogle Scholar
  123. Tidyman, W. E., & Rauen, K. A. (2009). The RASopathies: Developmental syndromes of Ras/MAPK pathway dysregulation. Current Opinion in Genetics & Development, 19(3), 230–236.CrossRefGoogle Scholar
  124. Tinker, J., Carbone, P. S., Viskochil, D., Mathiesen, A., Ma, K. N., & Stevenson, D. A. (2014). Screening children with neurofibromatosis type 1 for autism spectrum disorder. American Journal of Medical Genetics Part A, 164A(7), 1706–1712.PubMedCrossRefGoogle Scholar
  125. van der Vaart, T., Plasschaert, E., Rietman, A. B., Renard, M., Oostenbrink, R., Vogels, A., et al. (2013). Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): A randomised, placebo-controlled trial. The Lancet Neurology, 12(11), 1076–1083.PubMedCrossRefGoogle Scholar
  126. van der Vaart, T., Rietman, A. B., Plasschaert, E., Legius, E., Elgersma, Y., Moll, H. A., et al. (2016). Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1. Neurology, 86(2), 154–160.PubMedPubMedCentralCrossRefGoogle Scholar
  127. Van Eeghen, A. M., Pulsifer, M. B., Merker, V. L., Neumeyer, A. M., Van Eeghen, E. E., Thibert, R. L., et al. (2013). Understanding relationships between autism, intelligence, and epilepsy: A cross-disorder approach. Developmental Medicine & Child Neurology, 55(2), 146–153.CrossRefGoogle Scholar
  128. Varni, J. W., Seid, M., & Rode, C. A. (1999). The PedsQL™: Measurement model for the pediatric quality of life inventory. Medical Care, 37(2), 126–139.PubMedCrossRefGoogle Scholar
  129. Vogels, T., Verrips, G., Koopman, H., Theunissen, N., Fekkes, M., & Kamphuis, R. (2000). TACQOL manual: Parent form and child form. Leiden: Leiden Center for Child Health and Pediatrics LUMC-TNO.Google Scholar
  130. Von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2008). The strengthening the reporting of observational studies in epidemiology [STROBE] statement: Guidelines for reporting observational studies. Gaceta Sanitaria, 22(2), 144–150.CrossRefGoogle Scholar
  131. Walsh, K. S., Velez, J. I., Kardel, P. G., Imas, D. M., Muenke, M., Packer, R. J., et al. (2013). Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1. Developmental Medicine & Child Neurology, 55(2), 131–138.CrossRefGoogle Scholar
  132. Wang, D. L., Smith, K. B., Esparza, S., Leigh, F. A., Muzikansky, A., Park, E. R., et al. (2012a). Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome. Genetics in Medicine, 14(12), 977–982.PubMedPubMedCentralCrossRefGoogle Scholar
  133. Wang, Y., Kim, E., Wang, X., Novitch, B. G., Yoshikawa, K., Chang, L.-S., et al. (2012b). ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities. Cell, 150(4), 816–830.PubMedPubMedCentralCrossRefGoogle Scholar
  134. Werling, D. M., & Geschwind, D. H. (2013). Sex differences in autism spectrum disorders. Current Opinion in Neurology, 26(2), 146–153.PubMedPubMedCentralCrossRefGoogle Scholar
  135. Williams, J., Scott, F., Stott, C., Allison, C., Bolton, P., Baron-Cohen, S., et al. (2005). The CAST (childhood Asperger syndrome test): Test accuracy. Autism, 9(1), 45–68.PubMedCrossRefGoogle Scholar
  136. Williams, V. C., Lucas, J., Babcock, M. A., Gutmann, D. H., Korf, B., & Maria, B. L. (2009). Neurofibromatosis type 1 revisited. Pediatrics, 123(1), 124–133.PubMedCrossRefGoogle Scholar
  137. Yeates, K. O., Swift, E., Taylor, H. G., Wade, S. L., Drotar, D., Stancin, T., et al. (2004). Short- and long-term social outcomes following pediatric traumatic brain injury. Journal of International Neuropsychological Society, 10(3), 412–426.CrossRefGoogle Scholar
  138. Yeates, K. O., Bigler, E. D., Dennis, M., Gerhardt, C. A., Rubin, K. H., Stancin, T., et al. (2007). Social outcomes in childhood brain disorder: A heuristic integration of social neuroscience and developmental psychology. Psychological Bulletin, 133(3), 535–556.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Anita K. Chisholm
    • 1
    • 2
  • Vicki A. Anderson
    • 1
    • 2
  • Natalie A. Pride
    • 3
  • Stephanie Malarbi
    • 1
    • 2
  • Kathryn N. North
    • 1
    • 2
  • Jonathan M. Payne
    • 1
    • 2
  1. 1.Murdoch Childrens Research InstituteRoyal Children’s HospitalMelbourneAustralia
  2. 2.Department of PaediatricsUniversity of MelbourneMelbourneAustralia
  3. 3.Institute for Neuroscience and Muscle ResearchThe Children’s Hospital at WestmeadSydneyAustralia

Personalised recommendations